Bellevue Life Sciences Acquisition Corp. entered into a purchase agreement for a private placement of an unsecured convertible promissory note in the principal amount of $200,000, for gross proceeds of $200,000 on June 23, 2023. The transaction included participation from returning investor Bellevue Global Life Sciences Investors LLC.

The Note is not interest bearing and is payable in full on the earlier of December 31, 2024 or the date on which the Company consummates an initial business combination.